At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
Industrial Air Pollution and Newborn Hearing Screening Failure
The connection between air pollution and hearing loss has been established for over a decade, with most research focusing on adults. Studies have also shown that…
EHDI Program Eliminated
On April 1, President Trump’s administration eliminated the entire branch of the Early Hearing Detection and Intervention (EHDI) program that works with states to analyze…
Speak Up Today: Modernize Medicare Payment Policy
Congress is preparing to take action on a budget reconciliation package the week of May 5, and now is a critical time for the audiology…